Antibody-coated tumor cell surface antigens (Ab-Ag complex)

Antibody-coated tumor cell surface antigens refer to the immune complexes formed when therapeutic monoclonal antibodies bind to specific proteins on the surface of cancer cells. This state of opsonization is the primary mechanism by which the innate immune system identifies and eliminates malignant cells during antibody therapy. The Fc portion of the bound antibodies acts as a ligand for Fc gamma receptors (FcγRs) expressed on effector cells, such as natural killer (NK) cells and macrophages (Nimmerjahn & Ravetch, 2008). Engagement of these receptors, particularly CD16a, triggers antibody-dependent cellular cytotoxicity (ADCC), leading to the release of cytotoxic granules and tumor cell lysis (Wang et al., 2015). Additionally, these complexes can facilitate antibody-dependent cellular phagocytosis (ADCP) or activate the classical complement pathway to induce complement-dependent cytotoxicity (CDC). The density and stability of these antibody-coated antigens are critical determinants of therapeutic efficacy for blockbuster drugs like rituximab and trastuzumab. Modern antibody engineering often focuses on enhancing the affinity of the antibody's Fc region for these surface complexes to maximize immune recruitment and overcome resistance mechanisms such as antigen shedding.

Other names

Opsonized tumor antigensTumor-bound antibody complexesIgG-antigen complexesADCC target complexesSurface-bound immune complexes

Therapeutic monoclonal antibodies bind to specific tumor-associated antigens (TAAs) on the cell surface, forming an opsonized complex. The Fc region of the bound antibody then recruits and activates immune effector cells, such as natural killer (NK) cells and macrophages, by binding to Fc gamma receptors (FcγRs). This engagement triggers Antibody-Dependent Cellular Cytotoxicity (ADCC), Antibody-Dependent Cellular Phagocytosis (ADCP), or the classical complement pathway leading to Complement-Dependent Cytotoxicity (CDC) (Nimmerjahn & Ravetch, 2008; Weiner et al., 2010).